JPWO2019079339A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019079339A5
JPWO2019079339A5 JP2020542534A JP2020542534A JPWO2019079339A5 JP WO2019079339 A5 JPWO2019079339 A5 JP WO2019079339A5 JP 2020542534 A JP2020542534 A JP 2020542534A JP 2020542534 A JP2020542534 A JP 2020542534A JP WO2019079339 A5 JPWO2019079339 A5 JP WO2019079339A5
Authority
JP
Japan
Prior art keywords
ring moiety
compound
antiviral
linking
rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020542534A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021500400A5 (https=
JP7466907B2 (ja
JP2021500400A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/056138 external-priority patent/WO2019079339A1/en
Publication of JP2021500400A publication Critical patent/JP2021500400A/ja
Publication of JPWO2019079339A5 publication Critical patent/JPWO2019079339A5/ja
Publication of JP2021500400A5 publication Critical patent/JP2021500400A5/ja
Application granted granted Critical
Publication of JP7466907B2 publication Critical patent/JP7466907B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020542534A 2017-10-18 2018-10-16 広域スペクトルの抗ウイルス治療のための組成物及び方法 Active JP7466907B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762573933P 2017-10-18 2017-10-18
US62/573,933 2017-10-18
PCT/US2018/056138 WO2019079339A1 (en) 2017-10-18 2018-10-16 COMPOSITIONS AND METHODS FOR BROAD SPECTRUM ANTIVIRAL THERAPY

Publications (4)

Publication Number Publication Date
JP2021500400A JP2021500400A (ja) 2021-01-07
JPWO2019079339A5 true JPWO2019079339A5 (https=) 2023-02-03
JP2021500400A5 JP2021500400A5 (https=) 2023-02-03
JP7466907B2 JP7466907B2 (ja) 2024-04-15

Family

ID=66173467

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020542534A Active JP7466907B2 (ja) 2017-10-18 2018-10-16 広域スペクトルの抗ウイルス治療のための組成物及び方法

Country Status (6)

Country Link
US (1) US12213955B2 (https=)
EP (1) EP3697404B1 (https=)
JP (1) JP7466907B2 (https=)
CN (1) CN111886008B (https=)
TW (1) TWI860281B (https=)
WO (1) WO2019079339A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018089306A1 (en) 2016-11-10 2018-05-17 Oyagen, Inc. Methods of treating and inhibiting ebola virus infection
CN112789925B (zh) * 2019-06-27 2023-06-02 Oppo广东移动通信有限公司 用于指示空间关系信息的方法和设备
US11738025B2 (en) 2020-02-04 2023-08-29 Oyagen, Inc. Method for treating coronavirus infections
AU2021235899A1 (en) * 2020-03-08 2022-10-13 Humanigen, Inc. Methods for treating coronavirus infection and resulting inflammation-induced lung injury
US11628165B1 (en) * 2020-03-25 2023-04-18 Helen Feng Method of boosting immune system against viral infection
ES2862462B2 (es) * 2020-04-06 2023-04-27 Servicio Andaluz De Salud Compuestos para la profilaxis y/o el tratamiento del sindrome de dificultad respiratoria aguda
WO2021211738A1 (en) * 2020-04-15 2021-10-21 Sanford Burnham Prebys Medical Discovery Institute Methods and compositions for antiviral treatment
WO2021226479A1 (en) * 2020-05-07 2021-11-11 The Regents Of The University Of California Inhaled statins for treatment of viral respiratory diseases
BR112022023746A2 (pt) * 2020-05-22 2023-02-07 Alberto Riveros Carlos Sistema, método e uso de um determinado medicamento para reduzir a replicação viral na mucosa das vias aéreas
WO2021249240A1 (zh) * 2020-06-11 2021-12-16 养生堂有限公司 Palovarotene在抗hbv病毒治疗中的用途
US20240131036A1 (en) * 2020-07-02 2024-04-25 The Uab Research Foundation Compositions and methods of treating conditions
CN112390731B (zh) * 2020-11-16 2022-11-25 成都大学 一种具有多靶点的维甲酸类衍生物及其制备方法与应用
US11998562B2 (en) 2021-01-25 2024-06-04 University Of South Florida Ophthalmological formulations for the prevention of a coronavirus infection
CN117062611A (zh) 2021-01-26 2023-11-14 惠和生物技术(上海)有限公司 嵌合抗原受体（car）构建体和表达car构建体的nk细胞
US20220378727A1 (en) * 2021-05-14 2022-12-01 The University Of Hong Kong Dry powder formulations of tamibarotene for pulmonary and intranasal delivery
CN116891497B (zh) * 2022-04-02 2025-12-16 上海旭成医药科技有限公司 视黄酸受体激动剂、其制备方法、中间体、药物组合物和应用
WO2023210634A1 (ja) * 2022-04-28 2023-11-02 国立大学法人東海国立大学機構 拡張障害を伴う心不全の治療用医薬組成物
CN119454680B (zh) * 2024-12-06 2025-06-17 华南农业大学 贝沙罗汀在制备抗prrsv或治疗猪蓝耳病的药物中的应用
CN121177272A (zh) * 2025-11-10 2025-12-23 北京市农林科学院 化合物am580在预防或治疗塞内卡病毒病中的用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7341717B2 (en) 2001-04-13 2008-03-11 Gpc Biotech Ag Therapeutic targets for treatment of HCV infections, methods of treating HCV infections and compounds useful therefor
US20060151574A1 (en) * 2002-11-29 2006-07-13 Gpc Biotech Ag Formulations useful against hepatitis C virus infections
WO2005120479A1 (en) * 2004-06-09 2005-12-22 Gpc Biotech Ag Use of selenium or a selenium salt and a retinoid acid or a retinoid in the treatment of viral hepatitis c
EP1886685A1 (en) 2006-08-11 2008-02-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods, uses and compositions for modulating replication of hcv through the farnesoid x receptor (fxr) activation or inhibition
ES2609825T3 (es) * 2007-01-18 2017-04-24 Evolva Sa 1,3-Dioxanos sustituidos útiles como moduladores de PPAR
CN104662036B (zh) * 2012-04-25 2018-11-09 华辉安健（北京）生物科技有限公司 乙肝肝炎病毒功能性受体的组成以及相关应用
US20150290235A1 (en) * 2012-11-23 2015-10-15 Ab Science Use of small molecule inhibitors/activators in combination with (deoxy)nucleoside or (deoxy)nucleotide analogs for treatment of cancer and hematological malignancies or viral infections
KR20160113302A (ko) 2014-02-18 2016-09-28 칠드런＇스 하스피틀 로스 앤젤레스 호중구감소증을 치료하기 위한 조성물 및 방법
CA2942469C (en) * 2014-03-10 2024-06-11 Cornell University Combination therapy for head and neck cancer
WO2018054891A1 (en) 2016-09-20 2018-03-29 Ruprecht-Karls-Universität Compounds and combinations thereof for preventing and/or treating hbv and/or hdv infections

Similar Documents

Publication Publication Date Title
JPWO2019079339A5 (https=)
RU2324684C2 (ru) Пиримидиновые производные
JP2023113843A5 (https=)
JP2018534258A (ja) 潜伏ウイルスの転写制御のための組成物および方法
JP2024161350A5 (https=)
JP2017531038A5 (https=)
CN100400045C (zh) 基于核酸的化合物及其使用方法
JP2540576B2 (ja) 抗レトロウイルスおよびｂ型肝炎剤
JP2006528643A5 (https=)
JP2012505836A5 (https=)
EA201370186A1 (ru) 1-метилэтиловый сложный эфир n-[(2'r)-2'-дезокси-2'-фтор-2'-метил-p-фенил-5'-уридил]-l-аланина и способ его получения
RU2367650C2 (ru) Циклоалкендикарбоновые кислоты как противовоспалительные, иммуномодулирующие и антипролиферативные средства
JP2005525991A5 (https=)
CN110382463A (zh) Hdac6选择性抑制剂及其制备方法和应用
JP2016513113A5 (https=)
CA2530075A1 (en) Amphiphilic pyridinium compounds, method of making and use thereof
CN109790123A (zh) 新型衣壳蛋白装配抑制剂
JP2009506122A5 (https=)
JP2008512474A (ja) ハロゲン化されたベンズアミド誘導体
CN115040511A (zh) Esi-09在防治gcrv感染中的应用
JP2008503221A5 (https=)
JP2899292B2 (ja) Ｂ型肝炎の抗ウイルス剤による治療方法
JPWO2022221227A5 (https=)
Zell et al. Ongoing evolution of swine influenza viruses: a novel reassortant
JPWO2021095828A5 (https=)